Sandra Franz

Dr Tomic-Canic is a William H. Eaglstein Chair in Wound Healing, Vice chair of Research and Professor and the Director of Wound Healing and Regenerative Medicine Research Program at the Dr Phillip Frost Department of Dermatology and Cutanelous Surgery at the University Of Miami Miller School of Medicine. Her current research is focused on: molecular/cellular mechanisms of wound healing and its inhibition; developing new therapeutics and diagnostics; anti-inflammatory processes in wound healing and wound infection/host response. Her research has been continuously funded by the NIH for 25 years. Dr Tomic-Canic has participated in national scientific and clinical panels discussing the immense need for translational research areas to improve clinical outcomes of wound healing. She currently serves as a Section Editor for Journal of Investigative Dermatology and a Senior Editor of the Wound Repair and Regeneration Journals. She is recognized national and international leader and inventor in the field of wound healing research and was honored by NIH with WALS Lectureship. She served to Advisory Council of the NIH/NINR and was appointed to The Big Data to Knoledge Multi-Council Working Group. Very active member of the Wound Healing Society and Wound Care Collaborative COmmunity. She served as a WHS Program Chair in 2011, as a member of the Board of Directors, Executive Board and was the WHS President in 2016-2017. Her scientific contributions to the field of wound healing and her leadership were recognized by the 2022 Wound Healing Society's Lifetime Achievement Award and 2025 Distinguished Service Award.

Susan W. Volk, VMD, PhD is the Corinne R and Henry Bower Professor of Small Animal Surgery at the University of Pennsylvania School of Veterinary Medicine. As a clinician-scientist, she has had a long-standing clinical interest in wound healing, with a complimentary basic research program focused on cell-extracellular matrix in modulating progenitor and reparative cell activities during tissue repair. Recent work from her laboratory has defined cell-matrix interactions that regulate the wound healing-fibrosis-cancer triad. This NIH, private foundation, and industry-sponsored research has basic and translational components, including clinical trials in veterinary patients. Dr. Volk serves as President of the Wound Healing Society and as a member of the Board of Directors of the North American Veterinary Regenerative Medical Association.

Dr. Kirsner is Chairman, Tenured Professor and the endowed Harvey Blank Chair in the Dr. Phillip Frost Dermatology in the Department of Dermatology and Cutaneous Surgery and Professor of Public Health Sciences at the University of Miami Miller School of Medicine. He is Chief of Dermatology at the University of Miami Hospital and Clinics and Jackson Memorial Hospital and directs the University of Miami Hospital Wound Center. Dr. Kirsner received his undergraduate degree from Texas A&M University, his medical degree from the University of Miami and a PhD in epidemiology from the University of Miami, after he completed his clinical training. His clinical training included internal medicine, a clinical and research fellowship in wound healing and dermatology at the University of Miami. His research interests include Wound Healing and Skin Cancer Epidemiology. Dr. Kirsner serves as one of 3 academic editors for the journal Wound Repair and Regeneration and on the editorial boards for several other journals in dermatology and wound healing. Dr. Kirsner serves in national leadership positions in both Wound Healing and Dermatology, including serving as past Vice President of the American Academy of Dermatology and is currently President of the Wound Healing. In addition to career development awards, foundation, industry sponsored funding and CDC funding, he currently leads or is part of several NIH funded grants. Independent of books, book chapters and abstracts, he has published over 650 articles.

Dr. Kanhaiya Singh is an Associate Professor at the Department of Surgery, University of Pittsburgh. Dr. Singh received his doctoral degree in Biotechnology from Banaras Hindu University, India. Prior to joining University of Pittsburgh, Dr. Singh served as an Assitant Professor at Indiana University. His research focus is on epigenetic mechanisms of gene expression during diabetic vasculopathy and includes single-cell transcriptomics and single-cell ATAC sequencing approaches to investigate the molecular pathways that are compromised. His laboratory is also investigating the epigenetic mechanisms such as DNA methylation as a proxy for abnormal gene–environmental interactions in diabetic ischemic wounds. Current line of study aims to develop a simple and point of care approach to achieve targeted epigenetic editing of adult diabetic ischemic tissue in vivo. To that end, his team is employing Tissue Nanotransfection (TNT) technology as a delivery platform to administer combination gene therapy for diabetic ischemic tissue rescue. This research is funded through peer-reviewed grants from Department of Defense (DoD) and NIH-NIDDK. Dr. Singh has authored more than 50 peer reviewed publications. Dr Singh has been an Editorial Boards peer reviewed journals such as Scientific Reports, Plos One, Frontiers in Endocrinology and Heliyon. In this role, he has edited more than 200 publications and 4 special issues. He serves as active member of Wound Healing Society and American Diabetes Association.